Journal
MOLECULAR BRAIN RESEARCH
Volume 77, Issue 1, Pages 138-147Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/S0169-328X(00)00042-5
Keywords
microglia; lipopolysaccharide; NF-kappa B; interleukin-6; interleukin-10
Categories
Funding
- NIDDK NIH HHS [DK51576] Funding Source: Medline
Ask authors/readers for more resources
The purpose of this study was to determine if interleukin (IL)-10 inhibits lipopolysaccharide (LPS)-induced IL-6 production in microglia by inhibiting activation of nuclear factor-kappa B (NF-kappa B). N13 microglia (a murine microglial cell line) and primary microglia from neonatal mice were cultured in the presence or absence of LPS and increasing amounts of murine IL-10 for 24 h. As predicted, LPS treatment increased supernatant IL-6 concentration in both N13 and primary microglia cultures. Pretreatment with IL-10, however, decreased LPS-induced IL-6 secretion in a dose-dependent manner in both culture systems. Likewise, ribonuclease protection assays showed that LPS increased steady-state IL-6 mRNA levels, but that pretreatment with IL-10 blocked the LPS-induced increase in IL-6 mRNA. Because NF-kappa B is the predominant transcription factor responsible for IL-6 transcription in response to inflammatory stimuli, it was hypothesized that IL-10 inhibited IL-6 production by preventing nuclear translocation of NF-kappa B. Consistent with this idea, LPS increased nuclear translocation of NF-kappa B as assessed by gel mobility shift assay. Supershift assays and immunocytochemical staining showed that both the p50 and p65 subunits of NF-kappa B translocated from the cytoplasm to the nucleus upon LPS stimulation. Pretreatment with IL-10, however, inhibited LPS-induced activation of NF-kappa B. Furthermore, inhibition of NF-kappa B activity with tosyl-Phe-chloro-methlyketone (a serine protease inhibitor that prevents degradation of the NF-kappa B-I kappa B complex), completely blocked LPS-induced IL-6 production. These data suggest that IL-10 inhibited IL-6 production in microglia by decreasing the activity of NF-kappa B and, therefore, extend what little is known of the intricate relationship between anti-inflammatory and inflammatory cytokines in the central nervous system. (C) 2000 Elsevier Science B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available